NASDAQ: NXGL · Industrial Applications and Services · 7 alerts · CIK 1468929
Share price
$3.93Close, Nov 16
Market cap
$2.11M
Shares outstanding
536.11KLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nexgel, Inc. filings on SEC EDGAR ↗
NEXGEL, INC. reported a net loss of $5.68 million for the nine months ended September 30, 2026, compared to $2.03 million in the prior year, driven by significant increases in selling, general, and administrative expenses. Total assets grew to $23.90 million following a major $12.34 million increase in intangible assets, while the company underwent a 1-for-20 reverse stock split in October 2026.
Nexgel Interim CEO Brian Joseph Kieser Buys $733K of Stock
Brian Joseph Kieser, Interim CEO, bought 133,216 shares of Nexgel, Inc. at $5.50 a share, worth $733K in total on Nov 10, 2026. Shares held after the trade: 133,216.
Nexgel Insider steven mark glassman Buys $25K of Stock
steven mark glassman bought 4,546 shares of Nexgel, Inc. at $5.50 a share, worth $25K in total on Nov 10, 2026. Shares held after the trade: 12,379 (+58.0%).
NEXGEL announced a strategic recapitalization and update on a potential merger with Fountainhead LifeSciences, including its affiliates Sequence LifeScience and NVISION Biomedical Technologies. As part of the plan, holders of $14.125 million in convertible notes (95% of outstanding principal) agreed to convert their debt into common stock at $5.50 per share, contingent upon the completion of the merger.
NexGel, Inc. has announced a 1-for-20 reverse stock split of its common stock, effective October 12, 2026. The split aims to consolidate every twenty shares into one share to adjust the per-share trading price while maintaining the par value at $0.001. The common stock will continue to trade on The Nasdaq Capital Market under the ticker 'NXGL' with a new CUSIP number.
NexGel, Inc. has released a new shareholder update presentation titled 'Strategic Review & Proposed Platform Reorganization.' The presentation outlines the company's strategic direction and proposed changes to its business platform to drive future growth.
NexGel stockholders approved an amendment to the Certificate of Incorporation to effect a discretionary reverse stock split at a ratio between 1-for-2 and 1-for-20. Stockholders also approved increasing the number of authorized shares of common stock from 25 million to 150 million.